글로벌 스마트 당뇨병 관리 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

스마트 당뇨 관리 시장 분석

스마트 당뇨병 관리 시장은 기술의 발전과 개인화된 건강 관리에 대한 강조가 커지면서 빠르게 진화하고 있습니다. 이 시장은 스마트 포도당 측정기, 지속적인 포도당 모니터링 시스템, 당뇨병 관리를 강화하는 인슐린 투여 솔루션을 포함한 다양한 기기를 포함합니다. 전 세계적으로 당뇨병 유병률이 증가함에 따라 실시간 모니터링과 데이터 분석을 용이하게 하는 혁신적인 솔루션에 대한 수요가 증가하고 있습니다. 대기업 간의 협업과 스마트폰 통합 포도당 모니터와 같은 신제품 출시와 같은 최근의 발전은 사용자 경험과 접근성을 향상시키고 있습니다. 또한 지속적인 연구와 파트너십은 디지털 건강 애플리케이션을 통해 치료 준수와 환자 결과를 개선하는 것을 목표로 합니다. 의료 시스템이 예방 치료와 자기 관리로 전환함에 따라 스마트 당뇨병 관리 시장은 상당한 성장을 향해 나아가고 있으며, 의료 생태계의 이해 관계자들에게 유망한 기회를 제공합니다.

스마트 당뇨 관리 시장 규모

글로벌 스마트 당뇨병 관리 시장 규모는 2023년에 74억 4천만 달러로 평가되었으며, 2031년까지 227억 6천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 15.00%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

스마트 당뇨 관리 시장 동향

“ 인공지능의 통합”

스마트 당뇨병 관리 시장은 환자 치료를 개선하는 기술 혁신에 의해 주도되는 혁신적인 추세를 목격하고 있습니다. 두드러진 추세 중 하나는 인공 지능(AI) 과 머신 러닝을 당뇨병 관리 도구에 통합하는 것입니다. 이러한 기술은 포도당 모니터와 웨어러블 기기에서 방대한 양의 데이터를 분석하여 사용자에게 개인화된 통찰력과 권장 사항을 제공합니다. 스마트 인슐린 펜 및 폐쇄 루프 시스템과 같은 혁신도 인기를 얻고 있으며, 실시간 포도당 판독을 기반으로 자동 인슐린 투여가 가능합니다. 이러한 추세는 치료에 대한 준수를 개선하고 환자가 건강을 스스로 관리할 수 있도록 합니다. 결과적으로 시장은 더욱 사용자 친화적이고 효과적인 솔루션을 제공하도록 진화하여 당뇨병 관리 결과를 크게 개선하고 있습니다.

보고서 범위 및 스마트 당뇨병 관리 시장 세분화         

Smart Diabetes Management Market Definition

Smart diabetes management is the use of advanced technology and digital tools to monitor and manage diabetes effectively, encompassing devices and applications that enable real-time tracking of blood glucose levels, personalized insights, and enhanced communication between patients and healthcare providers.

Smart Diabetes Management Market Dynamics

Drivers

• Rising Prevalence of Diabetes

The rising prevalence of diabetes worldwide is significantly driving the demand for effective management solutions. With an estimated 537 million adults living with diabetes as of 2021, this number is projected to rise sharply in the coming years due to factors such as sedentary lifestyles, poor dietary habits, and genetic predispositions. As a result, there is a pressing need for innovative tools and technologies that can help individuals monitor and manage their condition effectively. Smart diabetes management solutions, such as continuous glucose monitors and insulin delivery systems, provide real-time data and personalized insights, empowering patients to take control of their health. This urgent demand for efficient management options is propelling growth in the smart diabetes management market, making it a critical area for investment and development.

• Consumer Demand for Personalization

The shift towards personalized healthcare is significantly influencing the development of tailored diabetes management solutions. As patients increasingly seek customized care that aligns with their individual health needs and lifestyles, healthcare providers are responding by adopting technologies that offer personalized insights and recommendations. Innovations such as smart glucose meters and mobile health applications allow for individualized monitoring and treatment adjustments based on real-time data. This trend enhances patient engagement and adherence and improves health outcomes by providing targeted interventions. Consequently, the demand for personalized diabetes management tools is driving growth in the smart diabetes management market.

Opportunities

• Integration of Wearable Technology

The proliferation of wearable devices presents significant opportunities for seamless integration with diabetes management solutions, fundamentally transforming how individuals monitor and manage their condition. These devices, including smartwatches and fitness trackers, can continuously collect vital health data such as blood glucose levels, physical activity, and heart rate. By integrating this data with diabetes management apps, users receive real-time feedback and personalized insights, empowering them to make informed decisions about their health. This continuous monitoring capability enhances patient engagement and facilitates proactive management, reducing the risk of complications. As consumer demand for wearable technology grows, the smart diabetes management market can leverage this trend to develop innovative solutions that improve patient outcomes and enhance the overall management experience.

• Advancement in Telehealth Services

The increasing acceptance of telehealth services is creating substantial opportunities for enhancing diabetes management through remote monitoring and consultations. This shift allows healthcare providers to connect with patients virtually, offering them the convenience of managing their condition from the comfort of their homes. For individuals living in remote or underserved areas, telehealth can significantly improve access to specialized care and diabetes management resources. Patients can benefit from real-time data sharing with healthcare professionals, enabling timely interventions and personalized care plans. Additionally, telehealth services often include educational resources and support systems that empower patients to take charge of their health. As telehealth continues to gain traction, the smart diabetes management market stands to capitalize on this trend by integrating remote monitoring solutions that improve patient outcomes and overall healthcare efficiency.

Restraints/Challenges

• High Costs of Investment

The high initial investment associated with advanced diabetes management technologies poses a significant challenge to widespread adoption among patients and healthcare providers. Many of these innovative solutions, such as continuous glucose monitoring systems and smart insulin pumps, come with substantial upfront costs that can deter potential users. For patients, especially those without adequate insurance coverage, the financial burden may limit access to essential management tools, impacting their ability to effectively control their condition. Healthcare providers, particularly smaller clinics and practices, may also find it difficult to allocate budget for these technologies, leading to disparities in care. Consequently, the prohibitive costs associated with adopting advanced diabetes management solutions can hinder their integration into everyday healthcare practices, ultimately affecting patient outcomes and overall market growth.

•  Limited Market Awareness

A significant lack of awareness regarding the benefits and functionalities of smart diabetes management technologies can impede their adoption among potential users. Many patients and healthcare providers may not fully understand how these innovative tools—such as continuous glucose monitors and mobile health applications—can enhance diabetes management and improve health outcomes. This gap in knowledge can lead to misconceptions or hesitance in adopting these technologies, as individuals may prefer traditional methods they are more familiar with. Additionally, without adequate education and outreach efforts from healthcare providers and manufacturers, patients may miss out on valuable opportunities for improved disease management. As a result, this lack of awareness can limit the overall growth and effectiveness of smart diabetes management solutions in the market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Smart Diabetes Management Market Scope

The market is segmented on the basis of devices, device type, application, diabetes type, and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Devices

• Smart Glucose Meters
• Continuous Glucose Monitoring Systems
• Smart Insulin Pens
• Smart Insulin Pumps
• Closed Loop Systems

Device Type

• Handheld Devices
• Wearable Devices

Application

• Diabetes and Blood Glucose Tracking Apps
• Obesity and Diet Management Apps

Diabetes Type

• Type 1 Diabetes
• Type 2 Diabetes

End Use

• Home Healthcare
• Hospitals
• Specialty Diabetes Clinics

 Smart Diabetes Management Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, devices, device type, application, diabetes type, and end use as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the smart diabetes management market, primarily driven by the high prevalence of diabetes among its population. The region's favorable reimbursement policies further enhance access to advanced diabetes management technologies, making them more attainable for patients. Additionally, increased awareness and adoption of innovative solutions contribute to the robust growth of this market segment in North America.

The Asia-Pacific region is anticipated to experience the highest growth rate from 2024 to 2031, driven by the strategic focus of numerous established market players looking to expand their footprint in this dynamic market. This growing interest is fueled by the increasing prevalence of diabetes and the demand for advanced management solutions in the region. As companies invest in localized initiatives and innovative technologies, the Asia-Pacific market is poised for significant development and increased adoption of smart diabetes management solutions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Smart Diabetes Management Market Share

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 스마트 당뇨병 관리 시장 리더는 다음과 같습니다.

• 애벗(미국)
• PHC 홀딩스 주식회사(일본)
• 웰닥 주식회사(미국)
• 사노피(프랑스)
• Dexcom, Inc. (미국)
• DarioHealth Corp. (미국)
• 메드트로닉(아일랜드)
• B. Braun SE(독일)
• F. 호프만-라 로슈 유한회사(스위스)
• 인슐렛 코퍼레이션(미국)
• Ascensia Diabetes Care Holdings AG(스위스)
• Tandem Diabetes Care, Inc. (미국)
• LifeScan IP Holdings, LLC(미국)
• AgaMatrix(미국)
• Glooko Inc. (미국)

스마트 당뇨병 관리 시장의 최신 동향

• 2023년 4월, 선도적인 소프트웨어 회사인 Glooko, Inc.는 인슐린 투여 알고리즘 개발사인 Hedia와 글로벌 파트너십을 체결했습니다. 이 협업은 원격 환자 모니터링, 커넥티드 케어, 디지털 치료 기술을 결합한 상호 운용 가능한 솔루션을 만드는 것을 목표로 합니다. 이를 통해 볼러스 인슐린 투여에 대한 지침이 필요한 1형 및 2형 당뇨병 환자의 접근성을 향상하고자 합니다.
• 2023년 5월, 선도적인 글로벌 헬스케어 기술 기업인 Medtronic plc는 혁신적인 웨어러블 인슐린 패치로 유명한 EOFlow Co. Ltd.를 인수하기로 하는 확정적 계약을 발표했습니다. 이 인수는 자동화된 인슐린 투여 기능을 강화하고 환자의 당뇨병 치료를 간소화하는 것을 목표로 합니다. Medtronic은 EOFlow의 기술을 통합하여 당뇨병을 관리하는 개인에게 더 나은 서비스를 제공하기 위해 제품 제공을 확대하는 동시에 업계에서의 입지를 강화하고자 합니다.
• 2021년 10월, 로슈는 Zur Rose Group과 협력하여 당뇨병 환자와 간병인이 매일 복용하는 약물을 관리하는 데 대한 지원을 강화했습니다. 이 협력은 Roche Diabetes Care의 솔루션을 선도적인 타사 공급업체의 솔루션과 통합하여 보다 포괄적인 의료 생태계를 만드는 것을 목표로 합니다. 로슈와 Zur Rose Group은 혁신적인 의료 제품을 연결하여 당뇨병 환자의 전반적인 삶의 질을 개선하고자 합니다.

SKU-52324